Explore our high-purity recombinant proteins, synthetic peptide APIs, and chemical building blocks manufactured under strict cGMP protocols.
Insulin-Like Growth Factor 1 (Serum IGF-1) is a 70-amino acid single-chain polypeptide polypeptide with three intramolecular disulfide bonds, playing a fundamental role in mediating endocrine, paracrine, and autocrine cell proliferation, survival, and metabolic signaling. As an indispensable growth factor in human biological fluids and cellular microenvironments, commercial-grade Serum IGF-1 serves as a critical raw material for serum-free biopharmaceutical cell culture, immunoassay standardization, tissue engineering platforms, and therapeutic candidate discovery.
Traditional expression of single-chain growth factors in microbial fermentation frequently leads to misfolded inclusion bodies with truncated biological potency. Gentolex’s proprietary Oxidative Refolding & High-Resolution Chromatographic Isolation Platform ensures correct native disulfide pairing (Cys6-Cys48, Cys18-Cys61, and Cys47-Cys52), achieving a specific biological activity exceeding 1.0 × 10⁶ IU/mg as measured by cell proliferation assays using FDC-P1 cell lines.
The global demand for recombinant serum IGF-1 has expanded significantly beyond classical clinical endocrinology research into large-scale biomanufacturing, regenerative stem cell expansion, and advanced diagnostic immunoassays.
As the biopharmaceutical industry transitions away from Fetal Bovine Serum (FBS) toward chemically defined, animal-component-free (ACF) media, recombinant Serum IGF-1 has emerged as an essential growth factor for high-density CHO, HEK293, and stem cell cultures, drastically improving monoclonal antibody and viral vector yields.
In clinical chemistry, accurate serum IGF-1 quantification is pivotal for diagnosing growth hormone disorders, acromegaly, and metabolic syndromes. We supply high-purity OEM reference standards, calibrators, and custom antigen constructs for Chemiluminescent Immunoassay (CLIA) and ELISA platform manufacturers globally.
Advancements in 3D bioprinting and cartilage repair depend on sustained local release of serum IGF-1. Our OEM formulation services enable microencapsulated, scaffold-bound, or slow-release peptide hydrogel integration, fully tailored to global biomedical researchers.
Every batch of OEM Serum IGF-1 produced by Gentolex undergoes comprehensive analytical characterization, including Mass Spectrometry (ESI-MS), Reverse-Phase HPLC, Endotoxin Assay (LAL Test), and Amino Acid Sequence Verification.
| Analytical Parameter | Recombinant Human Serum IGF-1 (Research Grade) | cGMP Commercial Serum IGF-1 (Media / API Grade) | Methodology / Instrument |
|---|---|---|---|
| Chemical Structure & Sequence | 70 Amino Acid Residues (Single Chain) | 70 Amino Acid Residues (Identical to Native Human) | Edman Degradation / ESI-MS |
| Molecular Weight | 7649.0 Da (± 1.0 Da) | 7649.0 Da (± 0.5 Da) | MALDI-TOF / ESI Mass Spectrometry |
| Purity Grade | ≥ 95.0% | ≥ 98.5% (Single Peak Profile) | RP-HPLC (C18 Column) |
| Biological Activity | ≥ 8.0 × 10⁵ IU/mg | ≥ 1.2 × 10⁶ IU/mg (ED50 < 1.0 ng/mL) | In Vitro FDC-P1 Bioassay |
| Endotoxin Level | < 0.1 EU / µg of Protein | < 0.005 EU / µg of Protein (Ultra-Low) | Chromogenic LAL Assays |
| Host Cell Protein (HCP) | < 100 ppm | < 10 ppm (Undetectable Level) | ELISA / Western Blot |
| Host Cell DNA (HCD) | < 10 ng / mg | < 100 pg / mg | qPCR Threshold Detection |
| Physical Appearance | White Lyophilized Powder | Sterile, White Lyophilized Cake | Visual Inspection |
Gentolex Group has established localized operational footprints and customer support hubs to streamline cross-border regulatory compliance, cold-chain distribution, and technical consultation across primary global biotechnology clusters.
Providing direct regulatory assistance, local invoicing, and accelerated customs clearance for biopharmaceutical firms and research institutes across Mexico, Central, and South America.
Ensuring seamless distribution channels, technical auditing, and compliance support according to international biosecurity and pharmacopeial standards across the African continent and EMEA regions.
Full documentation packages including Certificate of Analysis (CoA), Drug Master File (DMF) technical packages, TSE/BSE-free certificates, and ISO 13485 quality control protocols supplied standard with bulk OEM contracts.
Our custom OEM Serum IGF-1 and API solutions adapt precisely to specific industrial and scientific operational parameters:
Challenge: A multi-national biomanufacturing enterprise experienced batch-to-batch variation in cell density when transitioning to serum-free basal media formulations.
OEM Solution: Gentolex provided a tailored, ultra-low endotoxin recombinant Serum IGF-1 variant (<0.001 EU/µg) with stabilized secondary structure. Incorporating this component at 10-50 ng/mL boosted specific cell proliferation rates by 42% while stabilizing glycosylation patterns in target monoclonal antibodies.
Challenge: An in-vitro diagnostic (IVD) manufacturer needed consistent reference standards with long-term lyophilized shelf stability for automated chemiluminescent microparticle assays.
OEM Solution: We developed a custom carrier-free, ultra-pure OEM Serum IGF-1 matrix with rigorous mass spectrometry validation, achieving a 36-month stability profile at -20°C and eliminating inter-lot analytical drift.
As dynamic bioprocessing trends demand greater efficiency and targeted cell interactions, Gentolex’s R&D team is actively pursuing Next-Generation IGF-1 Formulations and bioconjugation technologies:
Engineering site-specific mono-PEGylated Serum IGF-1 variants to extend in-vivo half-life and improve bio-availability in tissue repair formulations.
Developing yeast (Pichia pastoris) high-density secretion systems to eliminate animal-derived contaminants entirely from commercial production.
Custom PLGA microparticle packaging for sustained growth factor release in bio-scaffolds and advanced 3D tissue engineering.
Utilizing molecular dynamics modeling to optimize redox buffering, increasing refolding yields of complex peptide structures by over 25%.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
State-of-the-art analytical infrastructure and peptide synthesis platforms enabling custom sequence design, modifications, and scale-up manufacturing.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Stay informed with industry analysis, regulatory updates, and breakthrough scientific findings from our internal R&D experts.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of TKPRPGP sequence. Originally developed through neuropharmacological research, Selank serves as an important neuro-active candidate...
Read Full Article
As a professional Thymosin Beta-4 API manufacturer, we provide high-grade peptide raw materials for biotechnology companies, scientific organizations, and tissue repair application studies worldwide...
Read Full Article
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its biological activity related to tissue repair, gastrointestinal protection, and angiogenesis...
Read Full Article
With continuous development in neuroscience and peptide technology, Semax, a synthetic fragment derived from ACTH, has attracted global interest for its therapeutic bio-mechanisms...
Read Full Article
SS-31 API (Elamipretide, MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting cellular bioenergetics...
Read Full ArticleTechnical answers addressing procurement, regulatory compliance, storage, and custom OEM manufacturing parameters for Serum IGF-1.
Additional active ingredients, peptide raw materials, and high-purity research compounds from our catalog.
